Loading...
Images of Meritxell Bellet
(0 from 0 )1
0
0
News
Breast Cancer Updates From ESMO 2022
www.cancertherapyadvisor.com
21 Sept — ... approval,” said study discussant Meritxell Bellet Ezquerra, MD, PhD, of Vall d'Hebron Institute of Oncology in Barcelona, Spain. › home › news
Esmo – Trodelvy's improving trajectory might not matter ...
www.evaluate.com
7 Sept — Discussing the Tropics-02 data at Esmo, Dr Meritxell Bellet Ezquerra, from Vall d'Hebron Institute of Oncology, said: “No doubt this is a ... › events › conferences › esm...
New CDK4/6 Inhibitor Offers Benefits for Advanced-Stage ...
www.breastcancer.org
13 Sept — ... extension of dalpiciclib approval to the first-line metastatic breast cancer setting in the Chinese population,” Meritxell Bellet, MD, ... › research-news › new-cd...
TROPiCS-02 Update: Sacituzumab Govitecan Improves ...
ascopost.com
11 Sept — ... invited discussant Meritxell Bellet Ezquerra, MD, PhD, a senior researcher at the Vall d'Hebron Institute of Oncology in Barcelona. › news › september › tropics...
Telephone & Addresses
High p16 expression and heterozygous RB1 loss are ...
ideas.repec.org
by M Palafox · — Meritxell Bellet. (Vall d'Hebron Institute of Oncology Hospital Vall d'Hebron). Guillermo Villacampa. (Vall d'Hebron Institute of Oncology). › nat › natcom
Physicians & MDs
Adjuvant Ovarian Suppression in Premenopausal Breast Cancer
www.nejm.org
by PA Francis · · Cited by 741 — Prudence A. Francis, M.D.,; Meredith M. Regan, Sc.D.,; Gini F. Fleming, M.D.,; István Láng, M.D.,; Eva Ciruelos, M.D.,; Meritxell Bellet, ... › doi › full › nejmoa
Download Figures (PPT) - The Lancet
www.thelancet.com
... PhD, Prof Miguel Martin, MD, Gabor Rubovszky, PhD, Prof Harold J Burstein, MD, Meritxell Bellet-Ezquerra, MD, Kathy D Miller, MD, Nicholas Zdenkowski, ... › journals › lanonc › article
Network Profiles
LinkedIn: Meritxell Bellet - Clinical Research - Vall d´Hebron LinkedInes.linkedin.com › meritxellbellet
Ve el perfil de Meritxell Bellet en LinkedIn, la mayor red profesional del mundo. Meritxell tiene 3 empleos en su perfil. Ve el perfil completo en LinkedIn y ...
Interests
Extended adjuvant intermittent letrozole versus continuous ...
www.em-consulte.com
... Carsten Hielscher, Isolde Gröll, Ute Marie Mattner, Anita Prechtl, Tilmann Lantzsch, Eva Ciruelos, Isabel Garau, Meritxell Bellet, Miguel Angel Climent, ... › article › extended-adju...
The co-occurrence of cancer driver genes, key to precision medicine |...
www.eurekalert.org
... Meritxell Bellet, Violeta Serra & Patrick Aloy. Personalized cancer therapy prioritization based on driver alteration co-occurrence patterns.
Extended adjuvant intermittent letrozole versus continuous letrozole...
www.em-consulte.com
... Tilmann Lantzsch, Eva Ciruelos, Isabel Garau, Meritxell Bellet, Miguel Angel Climent, Rafael López, Juan Antonio Virizuela, Begoña Bermejo, Noelia Martinez ...
Business Profiles
Researchgate: Meritxell Bellet
Barcelona, Catalonia, Spain
Books & Literature
AACR 2016: Abstracts Google Books result
books.google.co.uk
Judit Grueso,1 Meritxell Bellet,1 Mafalda Oliveira,1 Cristina Saura,1 Emmanuelle di Tomaso,3 Giordi Camponigro, 3 Nicholas C. Turner, 2 Javier Cortés, ...
AACR Proceedings: Abstracts Google Books result
books.google.co.uk
Marta Palafox,1 María Teresa Herrera-Abreu,2 Meritxell Bellet,1 Mafalda Oliveira,1 Alejandra Bruna,3 Olga Rodriguez, 1 Marta Guzmán,1 Judit Grueso,1 ...
Immunotherapy as an Evolving Approach for the Treatment of ...
books.google.co.uk
... Mafalda Oliveira 1,4,5, Eva Ciruelos 1,6, Meritxell Bellet Ezquerra 1,4,5, Cristina Saura 1,4,5, Joaquin Gavilá 1,7, Sonia Pernas 1,8, Montserrat Muñoz ...
Recruiting Breast Cancer Clinical Trials World Wide For 2011
books.google.co.uk
... Spain, Contact: Meritxell Bellet, MD Analysis of a large number of clinical studies for breast Copyright
Related Documents
Bosutinib in Combination With the Aromatase Inhibitor Letrozole
theoncologist.onlinelibrary.wiley.com
by B Moy · · Cited by 27 — BEVERLY MOY,a PATRICK NEVEN,b FABIENNE LEBRUN,c MERITXELL BELLET,d BINGHE XU,e TOMASZ SAROSIEK,f LOUIS CHOW,g PAUL GOSS,a. CHARLES ZACHARCHUK,h ERIC LEIP,h ... › pdfdirect
Neoadjuvant Model as a Platform for Research in Breast ...
www.scienceopen.com
*Meritxell Bellet, MD, PhD, Medical Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Passeig Vall d'Hebron , ... › document
SOLTI TOT-HER3 Study Concept - ReadCube
www.readcube.com
... Eva Ciruelos1,6, Meritxell Bellet Ezquerra1,4,5,Cristina Saura1,4,5, Joaquin Gavilá1,7, Sonia Pernas1,8, Montserrat Muñoz1,2,3,Maria J. Vidal1,2,3, ... › articles › fonc
PI3K pathway (PI3Kp) dysregulation and response to...
hwmaint.meeting.ascopubs.org
Mafalda Oliveira, Alejandro Navarro, Leticia De Mattos-Arruda, Gessamí Sánchez-Ollé, Meritxell Bellet, Judith Balmaña, Patricia Gómez-Pardo, Jose
Scientific Publications
Findings from the Phase II BioPER Trial - PubMed
pubmed.ncbi.nlm.nih.gov
by J Albanell — ... Giuseppe Curigliano , Manuel Ruíz Borrego , Laura Comerma , Joan Gibert , Meritxell Bellet , Begoña Bermejo , Lourdes Calvo , Juan de la ... by M Palafox · — Marta Palafox , Laia Monserrat , Meritxell Bellet , Guillermo Villacampa , Abel Gonzalez-Perez , Mafalda Oliveira , Fara Brasó-Maristany ... › ...
Oral metronomic vinorelbine combined with endocrine therapy ...
breast-cancer-research.biomedcentral.com
by B Adamo · · Cited by 18 — Meritxell Bellet & Patricia Gómez-Pardo. SOLTI Breast Cancer Research Group, Barcelona, Spain. Meritxell Bellet, Laia Paré, Tomás Pascual, ... › artic...
Characterization of HER1 (c-erbB1) status in locally advanced breast...
pubmed.ncbi.nlm.nih.gov
Cristina Corzo , Ignacio Tusquets, Marta Salido, Josep Maria Corominas, Meritxell Bellet, Marta Suarez, Teresa Baró, Xavier Fabregat, Sergio Serrano, Francesc ...
Polysomy of chromosome 17 in breast cancer tumors showing an...
breast-cancer-research.biomedcentral.com
Marta Salido *, Ignasi Tusquets, Josep M Corominas, Marta Suarez, Blanca Espinet, Cristina Corzo, Meritxell Bellet, Xavier Fabregat, Sergi Serrano and Francesc Solé
Publications
Polysomy of chromosome 17 in breast cancer tumors showing an...
link.springer.com
Introduction One of the most common genetic aberrations associated with breast cancer is the amplification and overexpression of the ERBB2 proto-oncogene...
Meritxell Bellet's Research | CureHunter
www.curehunter.com
Meritxell Bellet Selected Research. Meritxell Bellet Research Breast Neoplasms (Breast Cancer) Carcinoma (Carcinomatosis)
Oalib search
www.oalib.com
Marta Salido, Ignasi Tusquets, Josep M Corominas, Marta Suarez, Blanca Espinet, Cristina Corzo, Meritxell Bellet, Xavier Fabregat, Sergi Serrano, Francesc ...
Video & Audio
Efectos secundarios de los principales tratamientos en cáncer ...
www.youtube.com
17 Jun — Ponencia impartida por la Dra. Meritxell Bellet (Vall d'Hebron Instituto de Oncología) en el Taller para Pacientes con cáncer de mama del › watch
Reports & Statements
High p16 expression and heterozygous RB1 loss are Nature
www.nature.com
by M Palafox · — Meritxell Bellet, Mafalda Oliveira, Marta Capelán, Analía Azaro & Cristina Saura. Department of Medical Oncology, Hospital Vall d'Hebron, ... › nature communications › articles
HER2 and hormone receptor-positive breast cancer—blocking the right...
www.nature.com
Chemotherapy and trastuzumab is standard therapy for HER2-positive breast cancer, although aromatase inhibitors combined with anti-HER2 therapies is an option...
Tamoxifen and PAX2 stand as masters of death in breast ...cancercommunity.nature.com › posts › tamoxifen-and-...
cancercommunity.nature.com
Meritxell Bellet (Vall Hebron Institute of Oncology and Vall Hebron University Hospital, Barcelona, Spain). Antoni Hurtado (Cancer Genomics ...
Miscellaneous
Meritxell Bellet's research works | University Hospital Vall d ...
www.researchgate.net
› Meritxell-Bellet
Meritxell Bellet | LinkedIn
www.linkedin.com
View Meritxell Bellet's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Meritxell Bellet discover
A first-in-human phase I study to evaluate the oral selective ...
findanexpert.unimelb.edu.au
Komal Jhaveri, Eric Paul Winer, Elgene Lim, Jose AlejandroPerez Fidalgo, Meritxell Bellet, Ingrid Alina Mayer, Valentina Boni, Jaymin M Patel, Aditya Bardia ... › Scholarlywork
ABCSG-Publications (peer reviewed)
www.abcsg.com
... MD 25 ; Antonia Perell ´o, MD 26 ; Meritxell Bellet, MD; Hannes Fohler, MVM; Otto Metzger Filho, MD; Anita Jallitsch-Halper, PhD 2 ; Kadine Solomon, BA; ... › publications › abcsg-publicati...
Abstract OT : Solti HOPE: Real-world Altmetric
www.altmetric.com
Cancer Research, February · sabcs21-ot · Ana Casas, Eva Ciruelos, Mafalda Oliveira, Cristina Saura, Meritxell Bellet, Sonia Pernas, ... › details
Aims of the platform - Cyclibtool
www.cyclibtool.org
Meritxell Bellet, Medical Oncologist of the Breast Cancer Unit at Vall d'Hebron Hospital and Vall d'Hebron Institute of Oncology; SOLTI Governing Board ... › aims
Antibody-Drug Conjugate Prolongs Survival in Metastatic ...
www.medpagetoday.com
9 Sept — ... said ESMO invited discussant Meritxell Bellet-Ezquerra, MD, PhD, of Vall d'Hebron Institute of Oncology in Barcelona. › ... › ESMO
Breast tumors escape endocrine therapy by ER-independent ...
www.biorxiv.org
23 Sept — ... Anne-Lise Børresen-Dale, Kristine Kleivi Sahlberg, Therese Sørlie, Meritxell Bellet, Sandra Lopez-Aviles, Antoni Hurtado. › content
CTR Editors' Choice Award - The Oncologist Community
www.theoncologistcommunity.com
Beverly Moy, Patrick Neven, Fabienne Lebrun, Meritxell Bellet, Binghe Xu, Tomasz Sarosiek, Louis Chow, Paul Goss, Charles Zacharchuk, Eric Leip, ... › CTR-Edito...
CrossRef TDM - Journal of Korean Neurosurgical Society
www.jkns.or.kr
Octavi Córdoba, Meritxell Bellet, Xavier Vidal, Javier Cortés, Elisa Llurba, Isabel T. Rubio, Jordi Xercavins. The Breast ;21(3): Crossref logo. › journal › crossRefTDM
Gaining Further Perspective into Treatment of Advanced ...
themedicalxchange.com
21 Sept — Meritxell Bellet Ezquerra, Senior Researcher, Vall d'Hebron Institute of Oncology, Barcelona, Spain. An expert in metastatic breast cancer, Dr. › › 2455_g...
Identifican biomarcadores de resistencia a los inhibidores ...
isanidad.com
4 days ago — Cristina Saura y Meritxell Bellet, así como la Dra. Mònica Arnedos del Instituto Gustave Roussy de París. › ASP
Outcomes of patients with small and node-negative HER2 ...
mayoclinic.pure.elsevier.com
... Michael Untch, Meritxell Bellet-Ezquerra, Daniela Dornelles Rosa, Alvaro Moreno-Aspitia, Martine Piccart, Urania Dafni, Evandro de Azambuja. › publications › ou...
Overall survival (OS) results from the phase III TROPiCS
oncologypro.esmo.org
Presenter: Meritxell Bellet Ezquerra. Session: Proffered Paper session: Breast cancer, metastatic. Resources: Slides. Webcast. 09 Sep › ... › ESMO Congress
PARSIFAL: A randomized, multicenter, open-label, phase II ...
www.x-mol.com
Antonio Llombart-Cussac 1 , José Manuel Pérez-García 2 , Meritxell Bellet 3 , Florence Dalenc 4 , Miguel J. Gil Gil 5 , Manuel Ruiz Borrego 6 , Joaquín ... › paper › rec...
Palbociclib Rechallenge for Hormone Receptor-Positive ...
aacrjournals.org
by J Albanell — Meritxell Bellet. ORCID logo ;. Meritxell Bellet. Hospital Vall d'Hebron and Vall d'Hebron Institute of Oncology (VHIO) ... › doi › CCR
Palbociclib with adjuvant endocrine therapy in early breast ...
lacogcancerresearch.org
Erica L Mayer, Amylou C Dueck, Miguel Martin, Gabor Rubovszky, Harold J Burstein, Meritxell Bellet-Ezquerra, Kathy D Miller, Nicholas Zdenkowski, ... › palbociclib-with-adjuv...
Pregnancy after treatment of breast cancer in young women ...
www.thebreastonline.com
by O Córdoba · · Cited by 31 — Octavi Córdoba a,*, Meritxell Bellet a, Xavier Vidal b, Javier Cortés a, Elisa Llurba c, Isabel T. Rubio a,. Jordi Xercavins d a Breast Cancer Unit, ... › article › pdf
Related search requests for Meritxell Bellet
| Angel Climent Miguel Angel Climent Xavier Vidal | Mafalda Oliveira Javier Cortés Marta Palafox | Cristina Corzo Marta Suarez Marta Salido |
Person "Bellet" (1) Forename "Meritxell" (477) Name "Bellet" (246) |
sorted by relevance / date